Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-08

Clinical Trial Update: The Role of Vitamin D3 and Calcium Supplementation in Attenuating T2DM Severity [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated whether vitamin D3 with calcium supplementation could attenuate severity of Type 2 diabetes mellitus. The study conducted by York U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium supplement (Calcium)
  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: York University | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED